Skip to main content
. 2020 Oct 7;61:103056. doi: 10.1016/j.ebiom.2020.103056

Table 4.

Univariate and multivariate Cox regression analysis of of clinicopathological data correlated with OS in radiation-treated sarcoma.

Factors n Univariate
Multivariate (n=60)
HR (95% CI)a Pa HR (95% CI)b Pb
Sex (Male/Female) 73 1.218 (0.568-2.611) 0.613 •• ••
Age,years (≤62/>62) 73 1.547 (0.722-3.316) 0.262 1.819 (0.667-4.963) 0.242
Local disease recurrence (No/Yes) 60 2.964 (1.192-7.368) 0.019 3.139 (0.996-9.891) 0.051
Tumor depth (Superficial/Deep) 63 2.947 (0.395-21.961) 0.292 •• ••
Tumor necrosis percent (≤15/>15) 38 1.405 (0.503-3.928) 0.517 •• ••
Race (Other/White) 70 0.921 (0.216-3.927) 0.912 •• ••
New tumor event after initial Treatment
(No/YES) 46 111.064 (0.333-37090.821) 0.112 •• ••
Metastatic diagnosis (No/YES) 63 3.090 (1.330-7.180) 0.009 1.397 (0.437-4.465) 0.573
ASPM (low/high) 73 3.004 (1.323-6.820) 0.009 1.030 (0.180-5.893) 0.973
GTSE1 (low/high) 73 2.213 (1.006-4.868) 0.048 0.619 (0.097-3.972) 0.613
KIF18B (low/high) 73 4.179 (1.761-9.920) 0.001 7.773 (1.113-54.315) 0.039
UHRF1 (low/high) 73 2.228 (1.014-4.897) 0.046 0.863 (0.159-4.692) 0.864
DES (low/high) 73 3.458 (1.458-8.198) 0.005 2.721 (0.832-8.904) 0.098
CLIC5 (low/high) 73 0.372 (0.169-0.822) 0.014 0.471 (0.159-1.401) 0.176
CCDC69 (low/high) 73 0.372 (0.167-0.831) 0.016 0.285 (0.087-0.932) 0.038
a

P value, HR and 95% CI were assessed using univariate Cox regression analysis.

b

P value, HR and 95% CI were assessed using multivariate Cox regression analysis.

HR, hazard ratio; 95% CI, 95% confidence interval. OS, overall survival. ••, no data to display.